Analysis of patent litigation, PTAB practice, prosecution and pharma IP, written on the data behind LexDana.
Corcept Therapeutics experienced a significant drop in its stock value by 27% on Tuesday following an unfavorable verdict in a patent infringement lawsuit against Teva Pharmaceutical Industries (NASDAQ:TEVA). The ruling by a US District Court stated that…
Source: https://www.greyb.com/blog/drug-patents-expiring-2024/ The pharmaceutical industry is undergoing a important phase as numerous patents for key drugs are slated to expire in 2024. This impending expiration of patents signals a significant shift in…
The tech world has been abuzz with recent developments surrounding Apple's Watch Series 9 and Watch Ultra 2, as the ban on these models in the United States shakes the foundations of the company's market presence. President Joe Biden’s…
In late August of this year, our ANDA Intelligence 2023 Report was released, a comprehensive study, covering the Hatch-Waxman litigation within US district courts. The report focused on the period from July 1, 2018, through June 30, 2023, encapsulating a…
In a significant ruling on December 19, 2023, the German patent court invalidated a crucial patent that formed the core of CureVac's lawsuit against BioNTech, causing a notable impact on the stock market. Following Presiding Judge Walter Schramm's…
CASE OF THE WEEK ParkerVision, Inc. v. Vidal , Appeal No. 2022-1548 (Fed. Cir. December 15, 2023) In its only precedential patent decision last week, the Federal Circuit addressed both a claim construction issue and a procedural issue concerning inter…
In a groundbreaking move reported by 9to5Mac earlier today, Apple has officially announced the imminent cessation of sales for its flagship Apple Watch models, the Series 9 and Ultra 2, within the United States. This decision comes hot on the heels of an…
In response to the overwhelming interest in our weekly Insights, covering the entire spectrum of Intellectual Property (IP), we are excited to announce an expansion of our offerings. Patexia will now deliver a monthly Patent Insight Letter, specifically…
The Biden administration is exploring the use of "march-in" rights established in the 1980 Bayh-Dole Act , which has never been utilized before. This provision allows federal agencies to request licensing agreements for inventions developed under…
CASE OF THE WEEK VLSI Technology LLC v. Intel Corporation , Appeal No. 2022-1906 (Fed. Cir. December 4, 2023) In this week’s Case of the Week, the Federal Circuit vacated an approximately $2.2 billion damages award against appellant Intel Corporation…
The legal battle between chipmaker Intel Corporation and patent holding company VLSI has taken another turn as the US Court of Appeals for the Federal Circuit (CAFC) delivered a groundbreaking verdict . The CAFC decision, announced on December 4, 2023,…
CASE OF THE WEEK Penumbra, Inc. v. Rapidpulse, Inc. , IPR2021-01466, Paper 34 (P.T.A.B. March 10, 2023) In a PTAB decision that was recently designated precedential, the Board made two important decisions concerning provisional patent applications.…
